Diabetes News

Limited understanding of disease progression and frustration with disease management contribute to the clinical challenge of meeting the rising type 2 diabetes epidemic in America.

A potentially ground-breaking treatment for nerve damage caused by diabetes has shown promising results in preclinical and early patient trials.

Boca Medical Products is initiating a recall of 41 boxes of Closercare Insulin Syringe 29g 1cc product lot number 5JCZ1 as displayed on the inner case and 2320 boxes of Ultilet Insulin Syringe 30g 1/2cc product lot number 5KEO1 as displayed on the inner case.

Heart disease and diabetes are among the most common conditions plaguing Americans today, and they are related to a host of other diseases. Research now also demonstrates that these conditions can be warning signs for some types of digestive cancers.

Researchers have developed a novel technique to deliver insulin genes to the pancreas, the organ that produces the body's insulin. This approach is a major step in the potential treatment of Type I diabetes since patients with the disease do not produce enough insulin on their own.

Serum insulin concentrations provide an imprecise measure of beta cell mass, and no reliable non-invasive measure of beta cell mass has been available, until now.

While cases of premature death and a few other complications have declined, rates of other serious diabetes-related disorders such as heart and eye disease have not improved over the past 25 to 30 years.

An estimated 39,000 U.S. adolescents may have type 2 diabetes and more than 2.5 million may have impaired fasting glucose levels, which could lead to diabetes and other health problems.

The antidepressant sertraline may reduce the risk of recurrent depression and increase the period of time between episodes of depression in patients with diabetes.

A new mechanism for the formation of insulin crystals in the pancreas has been discovered.

Ghrelin, a hormone long considered a key player in obesity, may instead take a major role in maintaining the balance between insulin and glucose and the development of diabetes.

There is currently no evidence available that inhaled insulin (Exubera) in diabetes therapy shows advantages over short-acting human insulin or insulin analogues administered subcutaneously.

IDDM, which used to be referred to as Type 1 diabetes, results from selective destruction of insulin-producing pancreatic islet beta cells by the body's immune system.

A rare gene variant in humans helps to protect against two of the country's top killers -- type 2 diabetes and heart disease -- as well as against hypertriglyceridemia and pancreatitis.

A new study cites evidence in favor of using the protein biomarkers NGAL and IL-18 as a means to determine whether kidney transplant patients will require dialysis within the first week of transplant surgery.

Researchers have shown that blocking the action of a critical protein can improve multiple inflammatory pathways in patients with the metabolic syndrome.